SCHEMBL15628442

SCHEMBL15628442

CO[C@H](c1ccc(N2CCS(=O)(=O)CC2)cc1)[C@H](N)CF

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.40
▸ TGFBR1 P36897 1/20 0.35
▸ ACVR1 Q04771 1/20 0.35
▸ RORC P51449 2/20 0.35
▸ FAAH O00519 6/20 0.34
▸ ABHD6 Q9BV23 1/20 0.34
▸ PRMT5 O14744 1/20 0.34
▸ WDR77 Q9BQA1 1/20 0.34
▸ JAK2 O60674 1/20 0.33
▸ JAK3 P52333 1/20 0.33
▸ KDM5B Q9UGL1 1/20 0.32
▸ IGF1R P08069 1/20 0.32
▸ ADRB2 P07550 1/20 0.31
▸ ADRB1 P08588 1/20 0.31
▸ ADRB3 P13945 1/20 0.31
▸ ADRA1D P25100 1/20 0.31
▸ ADRA1A P35348 1/20 0.31
▸ ADRA1B P35368 1/20 0.31
▸ LDHA P00338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20026130 0.95 ALDH1A1 (0.42) ALDH1A1KDM4ETGFBR1ACVR1RORC
SCHEMBL15628607 0.85 ALDH1A1 (0.38) ALDH1A1KDM4EIGF1R
SCHEMBL15628457 0.84 ALDH1A1 (0.40) ALDH1A1KDM4E
SCHEMBL14023911 0.83 ALDH1A1 (0.41) ALDH1A1KDM4ERORC
SCHEMBL19062581 0.83 ALDH1A1 (0.41) ALDH1A1KDM4ERORC
SCHEMBL15628603 0.82 ADRB1 (0.48) ALDH1A1KDM4ETGFBR1ADRB2ADRB1
SCHEMBL14025102 0.80 KDM4E (0.47) ALDH1A1KDM4ERORCFAAHABHD6
SCHEMBL20026122 0.80 CA1 (0.41) —
SCHEMBL13527625 0.79 ALDH1A1 (0.41) ALDH1A1KDM4ETGFBR1ACVR1RORC
SCHEMBL20026111 0.78 AKR1C3 (0.47) ALDH1A1RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180094016-A1 Triazole Compounds And Methods Of Making And Using The Same BioVersys AG (CH) 2018-04-05 — — US disclosed
US-9006189-B2 Triazole compounds and methods of making and using the same MELINTA THERAPEUTICS, INC. (US) 2015-04-14 — — US disclosed
US-20140088031-A1 Triazole Compounds and Methods of Making and Using the Same RIB-X PHARMACEUTICALS, INC. (US) 2014-03-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180094016-A1 Triazole Compounds And Methods Of Making And Using The Same IL33, PROKR1, VIP ALDH1A1 3532/4885KDM4E 4532/4885TGFBR1 4556/4885
US-20140088031-A1 Triazole Compounds and Methods of Making and Using the Same IL33, PROKR1, VIP ALDH1A1 3532/4885KDM4E 4532/4885TGFBR1 4556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback